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A major cause of the high morbidity and mortality associated with measles infection is attributed to virus-mediated immunosuppression. In this
report, we present evidence for a novel strategy of immunosuppression by the measles virus. We observed a marked suppression of
lipopolysaccharide (LPS)-induced IL-8, RANTES, TNF-α and IL-6 production and NF-κB activation in human monocytic cell lines persistently
infected with measles virus. This effect was not observed in human epithelial cells lines persistently infected with measles virus. There were no
significant differences in expression levels of Toll-like receptors (TLRs) and their associated molecules, or other intracellular signaling molecules
of the NF-κB signaling pathway in measles-virus-infected monocytic cells compared to uninfected cells. Infected monocytic cells exhibited
decreased LPS-induced DNA binding of NF-κB and phosphorylation of JNK, namely activation of transcription factors NF-κB and AP-1. NF-κB
was constitutively activated in human epithelial cells persistently infected with measles virus, and LPS treatment resulted in further activation. The
cell-type-specific suppression of NF-κB activation represents a potential strategy of escape from the host immune system by measles virus via
induced immunological silencing in infected cells.
© 2006 Elsevier Inc. All rights reserved.Keywords: Measles virus; NF-κB; AP-1; Immunosuppression; Monocyte; Toll-like receptor; Signal transductionIntroduction
Measles is a highly contagious disease characterized by a
prodrome of fever, cough, coryza and conjunctivitis followed
by Koplik's spots and a generalized maculopapular rash. The
complications of measles, such as alveobronchiolitis and otitis
media, are generally believed to be caused by secondary
infections (Griffin, 2001; Oxman, 2002). Immunosuppression
by measles virus is considered to be a major cause of the high
morbidity and mortality rates of acute measles and the resultant
secondary complications. Encephalitides and alveobronchiolitis
are the major causes of death from measles virus infection.
Natural infection with the measles virus (MeV) is initiated
when the virus comes in contact with epithelial cells in the
respiratory tract, oropharynx or conjunctivae. MeV grows
rapidly in the epithelial cells of the respiratory tract, then
translocates into regional lymph nodes, at which point viremia⁎ Corresponding author. Fax: +81 11 612 5861.
E-mail address: fujii@sapmed.ac.jp (N. Fujii).
1 These authors equally contributed to this work.
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2006.11.002and the general symptoms of measles infection are manifest.
MeV is carried throughout the entire body by infected blood
cells such as monocytes and T-cells in the blood stream and
lymphatic fluids (Griffin, 2001). MeV has acquired several
mechanisms of immunosuppression, which enable the virus to
escape immune surveillance and inhibit attempts by the host
immune system to remove virus and virus-infected cells.
A number of putative molecular mechanisms of viral escape
from host immune defenses have been reported. During MeV
infection, lymphocytes are unresponsive to mitogens and
undergo cell cycle arrest at the G0/G1 transition (Engelking et
al., 1999; Naniche et al., 1999; Wang et al., 2003; Yanagi et al.,
1992). We previously reported that growth arrest also occurred
in epithelial cells infected with MeV due to upregulation of
interferon regulatory factor 1 (IRF-1). However, this likely
represents a host strategy of the defense system for suppressing
viral propagation rather than a viral strategy for escape from host
defense (Yokota et al., 2004). Viral H and F glycoproteins
expressed on the surface of infected cells directly inhibit T-cell
activation and proliferation through disruption of the Akt sig-
naling pathway (Avota et al., 2001). Cell-free viral nucleoprotein
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production by B cells though engagement of their Fcγ II
receptor (FcγRII) (Ravanel et al., 1997). MeV infection leads
dendritic cells to undergo abnormal maturation (Hahm et al.,
2004, 2005; Schneider-Schaulies et al., 2003; Servet-Delprat et
al., 2003). MeV infection impairs CD40 signal transduction in T-
cells and results in altered cytokine production and T-cell
proliferation (Servet-Delprat et al., 2000). Karp et al. (1996)
reported that MeV infection inhibits lipopolysaccharide (LPS)-
and Staphylococcus aureus Cowan I cell-induced interleukin
(IL)-12 production in human primary monocytes. MeV infection
also alters production of interferons (IFNs) and IFN-mediated
signal transduction. Naniche et al. (2000) reported that wild
MeV strains suppress type I IFN production in human peripheral
blood mononuclear cells (PBMC), while Vero cell-adaptedMeV
strains (laboratory strains) strongly induced type I IFN.
Schlender et al. (2005) reported that MeV inhibit Toll-like
receptor 7 (TLR7) and TLR9-mediated type I IFN production in
plasmacytoid dendritic cells. MeV-mediated suppression of IFN
signal transduction system is shown to be mediated in part by the
viral accessory protein V (Palosaari et al., 2003; Takeuchi et al.,
2003). We previously reported that IFN signaling is suppressed
to a similar extent in cells infected with wild and laboratory
strains of MeV (Yokota et al., 2003) (Okabayashi et al.,
submitted for publication).
In this study, we present evidence for a novel strategy of
suppression of the host immune response by MeV, namely
suppression of NF-κB and AP-1 activation in monocytic cells.
NF-κB is a transcriptional activator that plays a central role in
the host immune system, in both innate and adaptive
immunity, inflammation and cell proliferation and survival
(Hoffmann and Baltimore, 2006; Karin and Greten, 2005).
Activation of NF-κB results in upregulation of a large number
of genes, such as those that encodes proinflammatory
cytokines, chemokines, IFNs, cytokine receptors, adhesion
molecules, transcription factors, anti-apoptotic proteins and
anti-microbial proteins. Thus, through downregulation of NF-
κB, MeV-infected monocytic cells may escape rejection by
becoming immunologically silent.
Results
Suppression of proinflammatory cytokine and chemokine
production in human monocytic cell lines infected with MeV
We established several cell lines persistently infected with
MeV strain Hälle according to previously described methods
(Fujii et al., 1988, 1990). We assessed at least three
independent persistently infected lines for each cell line used
in the experiments of this study in order to exclude the
possibility of clonal selection during infection. Persistently
infected monocytic cell lines (THP-1 and U937) and epithelial
cell lines (SiHa and OSC70) produced constitutively infectious
virus at a similar level [approximately 103 plaque forming unit
(pfu)/ml].
THP-1 and U937 monocytic cells persistently infected with
MeV produced a similar amount of a chemokine IL-8 asuninfected cells (Fig. 1). LPS treatment upregulated IL-8
production in uninfected THP-1 and U937 cells following
differentiation by treatment with active vitamin D3. In contrast,
LPS-induced IL-8 production was suppressed in MeV-infected
THP-1 and U937 cells following active vitamin D3 treatment
(Figs. 1A and D). Suppression of IL-8 production was observed
not only with LPS (a TLR4 agonist) but also when cells were
stimulated with peptidoglycan (a TLR2 agonist) (Fig. 1B). On
the other hand, U937 cells persistently infected with mumps
virus constitutively produced a high level of IL-8 in the absence
of active vitamin D3 treatment and LPS stimulation (Fig. 1C).
SiHa and OSC70 epithelial cells persistently infected with MeV
constitutively produced markedly elevated levels of IL-8
compared to uninfected cells. While MeV-persistently-infected
SiHa and OSC70 cells highly produced IL-8, they showed still
more IL-8 induction by LPS treatment (Figs. 1E and F).
We also examined production of other proinflammatory
cytokines. Production of regulated upon activation normally T-
cell expressed and secreted (RANTES), tumor necrosis factor-α
(TNF-α) and IL-6 induced by LPS were also suppressed in
MeV-infected monocytic cell lines (Fig. 2). Induction of
RANTES (Figs. 2A and D) and TNF-α (Fig. 2C) by LPS
stimulation was suppressed in monocytic cell lines persistently
infected with MeV. U937 cells did not produce detectable
amounts of TNF-α. IL-6 production of THP-1 and U937 was
very low but significantly suppressed in MeV-infected cells
compared to uninfected cells (Figs. 2B and E).
We performed acute MeV infection experiment. We used
high infection dose at MOI 5 in the acute infection in order that
cells were fully infected with virus during the early time points.
During acute MeV infection, IL-8 production was induced in
THP-1 and U937 cells, compared to cells that did not receive
virus (Figs. 3 and 4A). The results suggested that suppression of
MeV-induced IL-8 production in MeV-infected monocytic cells
correlated with the establishment of the stationary infection
state, namely persistent infection. On the other hand, LPS-
induced upregulation of IL-8 was suppressed during acute MeV
infection as similar to MeV-persistently-infected cell lines.
Similar results were obtained for other MeV strains such as
Edmonston and a clinical isolate SMU (data not shown). In
contrast, infection with mumps virus also induced IL-8
production in THP-1 and U937 during acute infection, and
LPS-induced upregulation of IL-8 during acute mumps virus
infection was similar to that seen in uninfected cells (Fig. 3A).
We also performed acute infection experiment using human
monocyte/macrophage fraction derived from PBMC as normal
and primary cells. Human primary monocyte/macrophage
strongly induced IL-8 by the stimulation with LPS. Whereas
MeV (both strain Hälle and a wild strain AK1) infection weakly
induced IL-8, LPS stimulation did not induce so high IL-8
production compared to uninfected cells (Fig. 5). Fig. 5 shows a
representative result. Similar results were obtained by using
monocyte/macrophage fraction donated from three different
donors (data not shown). We also observed IL-6 and TNF-α
induction by LPS was suppressed in the acutely infected
primary monocyte/macrophage, as similar to IL-8 (data not
shown).
Fig. 1. IL-8 production induced by LPS in human monocytic cell lines and epithelial cell lines persistently infected with MeV. (A) THP-1 and MeV-infected THP-1
cells, which were pre-treated with active vitamin D3, were treated with E. coli LPS for 24 h. (B) THP-1 and MeV-infected THP-1 cells, which were pre-treated with
active vitamin D3, were treated with S. aureus peptidoglycan for 24 h. (C) Production of IL-8 in U937 cells and U973 cells persistently infected with MeVor mumps
virus under normal culture condition. The culture supernatants cultured for 24 h were collected. (D) U937 and MeV-infected U937 cells, which were pre-treated with
active vitamin D3, were treated with LPS for 24 h. (E) SiHa cells and MeV-infected SiHa cells were treated with 1000 ng/ml LPS for 24 h or not. (F) OSC70 cells and
MeV-infected OSC70 cells were treated with 1000 ng/ml LPS for 24 h or not. Light gray bar: uninfected cells; dark gray bar: cells persistently infected with MeV.
Concentrations of IL-8 in culture supernatants were determined by ELISA. The data represent the mean and standard deviation (±SD) of triplicate wells in one
experiment.
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observed in the epithelial cell lines T24 and OSC70 during
acute MeV infection (Figs. 4B and C). The viral mRNA levels
were comparable among the cells tested, THP-1, U937, T24 and
OSC70. These results suggested that cell-type-specific suppres-
sion of LPS-induced IL-8 production occurred as a result of
both acute and persistent MeV infection in monocytic cells.
Effect of antiviral agent ribavirin on LPS-induced IL-8
production in monocytic cell lines persistently infected with
MeV
To confirm that the suppression of LPS-induced IL-8
production was due to MeV infection, and not to selection of
an unresponsive clone during isolation of the persistently
infected cell lines, we examined elimination of virus in MeV-
infected cells by ribavirin, an antiviral agent. Ribavirin is
effective for MeV in vitro (Kirsi et al., 1983). The MeV-infected
THP-1 cells produce infectious virus at approximately 103 pfu/
ml. Ribavirin treatment reduced virus production under
detectable level by the plaque formation assay. Treatment
with ribavirin restored LPS-induced IL-8 production in THP-1
cells persistently infected with MeV to levels similar touninfected THP-1 cells (Fig. 6). This result indicated that the
suppression of LPS-induced IL-8 production was due to the
infection by MeV.
Suppression of NF-κB activity in human monocytic cell lines
persistently infected with MeV
Expression of IL-8 is mainly regulated at the levels of
transcription by NF-κB (Mukaida et al., 1994). We examined
NF-κB activity in LPS-treated and -untreated cells persistently
infected with MeV using an enzyme-linked DNA/protein
interaction assay (ELDIA) (Fig. 7). NF-κB activity was similar
levels in both non-infected and MeV-infected THP-1 and U937
cells (Figs. 7A and B). NF-κB was constitutively activated in
epithelial cells persistently infected with MeV (Fig. 7C).
Moreover, further activation of NF-κB was induced by LPS
treatment in the MeV-infected epithelial cells to levels similar to
that seen in uninfected cells. Transcriptional activity of NF-κB
was examined by luciferase reporter assay (Fig. 8). Luciferase
reporter under control of NF-κB was upregulated by treatment
with LPS in uninfected cells. In contrast, the basal levels of
luciferase reporter was significantly lower than that in
uninfected cells and the luciferase reporter was not upregulated
Fig. 2. RANTES, IL-6 and TNF-α production induced by LPS in human monocytic cell lines persistently infected with MeV. (A–C) THP-1 and MeV-infected THP-1
cells, which were pre-treated with active vitamin D3, were stimulated with E. coli LPS for 24 h. Concentrations of RANTES (A), IL-6 (B) and TNF-α (C) were
measured by ELISA. (D and E) U937 andMeV-infected U937 cells, which were pre-treated with active vitamin D3, were stimulated with LPS for 24 h. Concentrations
of RANTES (D) and IL-6 (E) were measured by ELISA. Light gray bar: uninfected cells; dark gray bar: cells persistently infected with MeV. The data represent the
mean and standard deviation (±SD) of triplicate wells in one experiment.
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with MeV. These results indicated that NF-κB activation
induced by both viral infection and LPS-stimulation is
suppressed in monocytic cells persistently infected with MeV.Fig. 3. Suppression of IL-8 production in acute MeV infection, but not in acute
mumps virus infection. (A) THP-1 cells treated with active vitamin D3 were
infected with MeV or mumps virus at an MOI of 5. Twelve or 24 h after
infection, infected cells were treated with 100 ng/ml E. coli LPS, or untreated,
and culture supernatants were harvested 12 h after treatment. The data represent
the mean±SD of triplicate wells in one experiment. (B) mRNA expression of
MeV HA and mumps virus V protein detected by RT-PCR.Expression of Toll-like receptors (TLRs) and other signal
transduction molecules involved in NF-κB activation in
monocytic cell lines persistently infected with MeV
We examined expression levels of TLRs, MD2 and CD14,
which are components of the receptor complexes for microbial
factors. TLR4, MD2 and CD14 are required for recognition of
LPS and LPS-mediated signal transduction (Fitzgerald et al.,
2004). There were no significant differences in the levels of all
TLRs tested and MD2 mRNA in uninfected THP-1 and MeV-
infected THP-1 cells (Fig. 9). The mRNA level of CD14 was
significantly elevated by MeV infection. In contrast, the levels
of TLR3, 7 and 8 and CD14 mRNA decreased in MeV-infected
U937 cells. We also examined the cell surface expression of
TLR2, TLR4 and CD14 in THP-1 (Fig. 10) and U937 (data not
shown) by flow cytometry. The levels of cell surface expression
well correlate with the mRNA levels. The differences in the
response to MeV infection between U937 and THP-1 cells
suggested that the changes in expression levels of these proteins
following MeV infection were not related to the suppression of
NF-κB in these cells.
We examined protein levels of intracellular signal transduc-
tion molecules involved in NF-κB pathway by Western blotting
analysis (Fig. 11). The protein levels of NF-κB p50 subunit,
MyD88, TRAF6, TAK1 and TAB2were not significantly altered
by persistent MeV infection in U937 and THP-1 cells. The levels
of p65/RelA, c-Rel and IκB increased in THP-1 cells persistently
infected with MeV, but we did not observe a similar increase in
the levels of these proteins in U937 cells persistently infected
with MeV. We were unable to detect IRAK in THP-1 cells, most
Fig. 4. Effect of MeV acute infection on virus-induced and LPS-induced IL-8
production in monocytic and epithelial cell lines. Cells were infected with MeV
at an MOI of 5. After infection, cells were treated with 100 ng/ml E. coli LPS for
12 h before the culture supernatants were harvested, or not treated.
Concentrations of IL-8 were measured by ELISA. Right panels indicate
mRNA expression levels of MeV HA determined by RT-PCR. GAPDH was
determined as a control. (A) U937 cells pre-treated with active vitamin D3. (B)
Uroepithelial cell line T24. (C) Oral squamous carcinoma cell line OSC70. The
data represent the mean±SD of triplicate wells in one experiment.
Fig. 5. Effect of MeV acute infection on virus-induced and LPS-induced IL-8
production in human primary monocyte/macrophage. Human monocyte/
macrophage fractions derived from a healthy adult were infected with MeV
Hälle or a wild strain AK1 at anMOI of 5. After 12 h infection, cells were treated
with 100 ng/ml E. coli LPS for 12 h, or not treated. Concentrations of IL-8 were
measured by ELISA. The data represent the mean±SD of triplicate wells in one
experiment.
Fig. 6. Effect of ribavirin on the suppression of LPS-induced IL-8 production in
THP-1 cells persistently infected with MeV. THP-1 cells persistently infected
with MeV and uninfected THP-1 cells were treated with 30 μg/ml ribavirin for
8 days with changing media every 2 days. Ribavirin-treated cells were
stimulated with active vitamin D3 for 16 h, then treated with 100 ng/ml E. coli
LPS for 12 or 24 h. The virus titer in culture supernatant was determined plaque
forming assay. Concentrations of IL-8 were determined by ELISA. The data
represent the mean±SD of triplicate wells in one experiment.
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blotting. The results suggested that the suppression of NF-κB
activation by MeV was not due to alternations in the expression
levels of the signaling molecules involved in NF-κB activation.
Suppression of JNK activation and AP-1 activity in human
monocytic cell lines persistently infected with MeV
We examined LPS-induced JNK phosphorylation in cells
persistently infected with MeV. TLR- and IL-1-receptor-
activated signaling pathways activate not only NF-κB, but
also MAP kinase-related signaling molecules, such as JNK (Lee
et al., 2000; Ninomiya-Tsuji et al., 1999). We found that LPS-
induced JNK phosphorylation was suppressed in monocytic cell
lines persistently infected with MeV (Fig. 12A). We also
examined the activity of transcription factor AP-1, which isdownstream of JNK, by luciferase reporter gene assay. Similar
to NF-κB (Fig. 8), AP-1 was not activated by LPS treatment in
THP-1 cells persistently infected with MeV, while it was
dramatically activated by LPS in uninfected THP-1 cells (Fig.
12B). These results indicated that MeV inhibited both LPS-
induced NF-κB and JNK activation. The mode of inhibition by
MeV infection seems to involve a common signaling pathway
for NF-κB and JNK.
Discussion
In this study, we found that activation of NF-κB and AP-1
was suppressed in MeV-infected monocytic cells. Generally,
NF-κB is rapidly activated following viral infection. Helin et al.
Fig. 8. Effect of MeV infection on LPS-induced NF-κB activation determined by
a reporter gene assay. THP-1 cells and THP-1 cells persistently infected with
MeV were transfected with reporter plasmid containing luciferase reporter gene
linked to tandem repeat of NF-κB binding motif (pNF-κB-Luc) and pRL-TK as
an internal reference of transfection efficacy. The transiently expressed
transfectants were subsequently incubated in normal condition for 24 h, and
then with active vitamin D3 for 12 h. The cells were treated with E. coli LPS for
12 h, or not treated. The resulting cells were lysed, and the luciferase activities in
the cell lysates were measured. All experiments were performed in triplicate. The
results are expressed as fold induction (±standard deviation), which is relative to
the value obtained from uninfected THP-1 cells without LPS treatment.
Fig. 7. Effect of MeV infection on LPS-induced NF-κB activation in monocytic
and epithelial cell lines. (A) THP-1 (light gray bar) and MeV-persistently-
infected THP-1 (dark gray bar) cells; (B) U937 and MeV-persistently-infected
U937 cells; and (C) OSC70 andMeV-persistently-infected OSC70 cells. THP-1,
MeV-infected THP-1, U937 and MeV-infected U937 cells were treated with
active vitamin D3 for 16 h, then treated with 100 ng/ml E. coli LPS. OSC70 and
MeV-infected OSC70 cells were treated with 100 ng/ml E. coli LPS. The cells
were harvested at the indicated times, and nuclear fractions were prepared. The
levels of activated NF-κB in the nuclear fraction were determined by ELDIA.
The specific binding of NF-κB to immobilized oligo DNAwas confirmed using
mutated oligo DNA and inhibition of binding using soluble oligo DNA (data not
shown). The data represent the mean±SD of triplicate wells in one experiment.
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epithelial cell line A549. Consistent with this, we observed that
viral infection activated NF-κB in the epithelial cells lines SiHa,
T24 and OSC70. In monocytic cell lines THP-1 and U937,
suppression of LPS-induced NF-κB activation occurred during
the early phase of acute infection of MeV, while suppression of
virus-induced activation occurred during steady state infection,
namely the persistent infection phase. The complete suppres-
sion of NF-κB and AP-1 was likely to require steady state of
infection. The suppression of NF-κB activity suggested to be
commonly possessed by MeV, including laboratory strains and
wild strains. Mumps virus, which is also belonging to
Paramyxoviridae, did not share such activity. The NF-κB and
AP-1 suppression influenced on the production of various
proinflammatory cytokines, such as IL-8, RANTES, IL-6 andTNF-α, induced by stimulants. Such suppression of proin-
flammatory cytokine induction was observed in persistently
infected monocytic cell lines and acutely infected primary
monocytes/macrophages and monocytic cell lines. Karp et al.
(1996) reported that human primary monocytes infected acutely
with MeV show suppressed IL-12 and macrophage inflamma-
tory protein-1β (MIP-1β) induction by LPS or S. aureus Cowan
1 cells. But induction of TNF-α, IL-6 and MIP1β was not
significantly altered in the MeV-infected monocytes compared
with uninfected cells. The reason of this contradictory result is
still unknown.
During viral infection, components of the virus are re-
cognized by pattern recognition molecules in host cells.
Recognition activates signaling pathways that result in,
among other things, activation of NF-κB. Pattern recognition
molecules toward virus identified to date are TLRs and
cytosolic proteins containing caspase-recruiting domain
(CARD), such as retinoic acid inducible gene-I (RIG-I) and
melanoma differentiation-associated gene-5 (mda5) (Hiscott et
al., 2006; Johnson and Gale, 2006). MeV was expected to be
recognized by various pattern recognition molecules. Viral
single-stranded RNA can be recognized by TLR7 and TLR8.
Viral double strand RNA can be recognized by RIG-I, mda5 and
TLR3 (Bowie and Haga, 2005; Hiscott et al., 2006; Johnson and
Gale, 2006). In addition, MeV hemagglutinin protein (HA)
interacts with TLR2 and activates NF-κB (Bieback et al., 2002).
These signals results in two immunological out-puts, namely
activation of NF-κB and production of type I IFNs. In the
current study, we found that MeV infection suppressed the
activation of NF-κB in monocytic cells. MeV suppressed both
virus-induced and LPS-induced NF-κB activation. We pre-
viously observed that MeV-infected U937 cells produced
markedly higher levels of type I IFNs (Yokota et al.,
unpublished results). Thus, MeV specifically suppressed NF-
κB activation and not IFN production in monocytic cells.
Furthermore, not only NF-κB activation, but also AP-1
activation (via phosphorylation of JNK), was suppressed by
MeV infection. MeV might inhibit signaling upstream of
Fig. 9. Expression levels of mRNA for TLRs and related molecules in MeV-
infected and -uninfected monocytic cells determined by real-time RT-PCR. Total
RNAwas prepared from THP-1 (lane 1), MeV-persistently-infected THP-1 (lane
2), U937 (lane 3) and MeV-persistently-infected U937 cells (lane 4) pre-treated
with active vitamin D3. And then, each cDNA was prepared from total RNA.
The expressions levels of TLR2, TLR3, TLR4, TLR7, TLR8, MD2 and CD14
were determined by real-time PCR using a specific TaqMan probe. The results
were normalized by the results of GAPDH, and then expressed as relative values
to the results obtained from respective uninfected cells. The experiments were
performed in triplicate. The results were presented as mean value±standard
deviation. The presence of MeV was confirmed by analysis of expression of
MeV HA mRNA by RT-PCR.
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activation (Lee et al., 2000; Ninomiya-Tsuji et al., 1999). The
detail molecular mechanism for suppression of these tran-
scription factors is being investigated.
Numerous effects on host cells have been proposed as
immunosuppressive strategies of MeV for evading the host
immune system as described in the Introduction section. We
propose that suppression of NF-κB activity represents another
putative immunosuppressive strategy of MeV that is utilized
specifically in monocytic cells, and not in epithelial cells, where
NF-κB is strongly activated by MeV infection (Helin et al.,
2001). For example, we showed that chemokine, such as IL-8
and RANTES, induction was suppressed in MeV-infectedmonocytic cells. The suppression of chemokines should impair
leukocyte, especially neutrophil, activation and recruitment of
the activated leukocytes to the foci of infection. Many viruses
have various strategies for suppression of chemokine produc-
tion and function (Glass et al., 2003; Mahalingam et al., 2001).
The determinants of the cell-type specificity of immunosup-
pression by MeV have yet to be elucidated. In MeV infection in
humans, the primary target is the airway epithelium. MeV
proliferates in airway epithelial cells and then goes on to infect
secondary targets, such as dendritic cells, lymphocytes and
monocytes. MeV spreads throughout the body by means of
infected monocytes and lymphocytes via the blood and
lymphatic fluids (Griffin, 2001; Oxman, 2002). Suppression
of NF-κB activation, which means immunologically silent, in
MeV-infected monocytic cells may be a strategy utilized by the
virus to escape rejection and allow the spread of infection via
the blood stream throughout the entire body.
Materials and methods
Cells and viruses
The human monocytic cell lines THP-1 and U937, the
human cervical squamous carcinoma cell line SiHa and the
human uroepithelial cell line T24 were obtained from the
American Type Culture Collection (ATCC, Manassas, VA). The
human oral squamous carcinoma cell line OSC70 was
previously described (Yonekura et al., 2003). All cells were
routinely cultured in RPMI-1640 medium containing 10% (v/v)
fetal bovine serum. Human monocyte/macrophage fraction
were prepared from PBMC derived from healthy adults as
described previously (Yokota et al., 2006). MeV strains, Hälle,
Edmonston, SMU and AK1, were described previously (Yokota
et al., 2004). Mumps virus strain Torii was used in this study. In
acute infection experiments, virus was infected at a multiplicity
of infection (MOI) of 5. THP-1, U937, SiHa, T24 and OSC70
cell lines persistently infected with MeV were established
according to the method previously described (Fujii et al., 1988,
1990). Virus titers were determined using a plaque forming
assay using Vero cells as the indicator cell.
TLR agonist treatment
THP-1 and U937 were pre-treated with 1×10−8 M 1α,25-
dihydroxyvitamin D3 (active vitamin D3) for 16 h before LPS
treatment. Suspension cells were inoculated at 5×105 cells /ml.
Adherent cells were grown to more than 90% confluent. The
cells were treated with 100 ng/ml (unless otherwise mentioned)
LPS derived from Escherichia coli O111:B4 (Sigma-Aldrich,
St. Louis, MO). In some cases, peptidoglycan was used instead
of LPS. S. aureus peptidoglycan was purchased from Fluka
(Steinheim, Switzerland).
Ribavirin treatment
Cells were treated with 30 μg/ml ribavirin (Sigma-Aldrich)
for 8 days. Every 2 days, culture medium was changed. Viral
Fig. 10. Cell surface expressions of TLR2, TLR4 and CD14 in MeV-infected and -uninfected THP-1 cells determined by flow cytometry. Cells were pre-treated with
active vitamin D3, stained with phycoerythrin-labeled antibody against TLR2, TLR4 or CD14 and analyzed by flow cytometry. Hatched lines indicate the levels of
staining using isotype-matched unrelated control antibodies.
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below the detection limit following ribavirin treatment. Treated
cells were subsequently treated with active vitamin D3 and LPS,
as described above.
Western blotting
Rabbit antibodies against NF-κB p50 and TAK1 were
purchased from Upstate Biotechnologies (Lake Placid, NY).
Rabbit antibodies against NF-κB p65 (RelA) (Ab-1) and c-Rel
(Ab-1) were purchased from Oncogene Research Products
(Cambridge, MA). Rabbit antibodies against MyD88 (HFL-Fig. 11. Protein levels of intracellular signaling molecules involved in NF-κB
activation in MeV-infected and -uninfected monocytic THP-1 and U937 cells.
Cells were pre-treated with active vitamin D3, and the protein expression of p50,
p65, c-Rel, IκBα, MyD88, IRAK, TRAF6, TAK1 and TAB2 were determined
by Western blot analysis. Actin was carried out as a control experiment. MeV
HA was determined as a control for MeV infection.296), TAB2 (H-300) and JNK1 (FL) and mouse monoclonal
antibodies against IRAK (F-4), TRAF6 (D-10) and phospho-
JNK (G-7) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Rabbit anti-IκBα antibody was purchased
from Cell Signaling (Beverly, MA).Fig. 12. Effect of MeV infection on LPS-induced JNK phosphorylation and
AP-1 activity determined by a reporter gene assay in THP-1 cells. (A) THP-1
cells and THP-1 cells persistently infected with MeV were treated with active
vitamin D3 for 16 h, and then treated with 100 ng/ml E. coli LPS. The cells were
harvested at the indicated time points after LPS treatment and lysed. Total
protein levels of JNK1 and phosphorylation state of JNK were determined by
Western blot using anti-JNK1 antibody and anti-phosphorylated JNK antibody,
respectively. (B) THP-1 cells and THP-1 cells persistently infected with MeV
were transfected with reporter plasmid containing luciferase reporter gene linked
to tandem repeat of AP-1 binding motif (pAP-1-Luc) and pRL-TK as an internal
reference of transfection efficacy. The transiently expressed transfectants were
subsequently incubated in normal condition for 24 h, and then with active
vitamin D3 for 12 h. The cells were treated with E. coli LPS for 12 h, or not
treated. The luciferase activities in the resulting cell lysates were measured. All
experiments were performed in triplicate wells in one experiment. The results
are expressed as fold induction (±standard deviation), which is relative to the
value obtained from uninfected THP-1 cells without LPS treatment.
302 T. Indoh et al. / Virology 361 (2007) 294–303Preparation of total cell lysates, SDS–polyacrylamide gel
electrophoresis and Western blotting were carried out as
previously described (Yokota et al., 2003). Alkaline phospha-
tase-conjugated anti-rabbit or anti-mouse immunoglobulin
antibodies (BioSource International, Camarillo, CA) and
bromochloroindolylphosphate/Nitro blue tetrazolium were
used as secondary antibodies and enzyme substrate for Western
blotting, respectively.
Reverse transcription real-time polymerase chain reaction
(RT-PCR)
Total RNA was isolated from cells using an RNeasy Mini
kit (Qiagen, Hiden, Germany). The cDNA was prepared
from total RNA by a Reverse Transcription System kit
(Promega, Madison, WI) using random primer. Real-time
PCR was performed using a TaqMan Gene Expression
Assays kit (Applied Biosystems, Foster City, CA) with 7300
Fast Real-Time PCR system (Applied Biosystems). TLR2, 3,
4, 7 and 8, MD2 and CD14 mRNAs were determined.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA
was determined as a control for normalization. The spe-
cificity of the reaction products was confirmed by perform-
ing real-time PCR directly using RNA preparation. MeV
hemagglutinin (HA) mRNA and mumps virus V protein
mRNA were detected using OneStep RT-PCR kit (Qiagen)
described previously (Yokota et al., 2003; Kubota et al.,
2001).
Flow cytometry
Flow cytometry was performed using FACSCalibur (Beck-
ton-Dickinson, San Jose, CA) as previously described
(Shimizu et al., 2004). Phycoerythrin-labeled mouse mono-
clonal antibodies against TLR2 (clone TL2.1), TLR4 (clone
HTA125) and CD14 (clone 61D3) and their isotype controls
(phycoerythrin-labeled mouse monoclonal IgG1 and IgG2a
antibodies) were purchased from eBioscience (San Diego,
CA).
Enzyme-linked immunosorbent assay (ELISA)
IL-8, RANTES, TNF-α and IL-6 in culture supernatants was
quantified using a respective ELISA Development kit (Gen-
zyme-Techne, Minneapolis, MN).
Enzyme-linked DNA/protein interaction assay (ELDIA)
Nuclear extracts of cells were prepared using NE-PER
Nuclear and Cytoplasmic Extraction Reagents (Pierce, Rock-
ford, IL). DNA binding of activated NF-κB was determined by
ELDIA (Benotmane et al., 1997; Yokota et al., 2004) using a
BD Mercury Transfactor NFkB p50 Kit (BD Bioscience). This
system measures proteins bound to immobilized double-
stranded oligonucleotides using specific antibodies. Binding
specificity to a particular DNA motif was confirmed by
inhibition experiments using unlabeled double-stranded com-petitor oligonucleotides at a concentration of 200 ng/well. The
following oligonucleotides were used as competitor (wild) and
as control (mutant) for NF-κB p50: wild, 5′-GCCATGGGGG-
GATCCCCGGGC-3′; mutant, 5′-GCCATGGGCCGATCCC-
CGGGC-3′.
Reporter gene assay using luciferases
Activity of transcription factors was determined by a dual
luciferase reporter assay by transiently transfecting reporter
plasmids containing either the binding motif of NF-κB or
AP-1. The reporter plasmids, pNF-κB-Luc and pAP-1-Luc
(PathDetect in Vivo Signal Transduction Pathway cis-
Reporting System), were purchased from Stratagene (La
Jolla, CA). pNF-κB-Luc and pAP-1-Luc harbor tandem
repeats of the enhancer elements (TGGGGACTTTCCGC)5
and (TGACTAA)7, respectively, upstream of the firefly
luciferase gene. Reporter plasmids (1 μg) and a reference
plasmid (0.1 μg of pRL-TK vector, harboring the HSV
thymidine kinase promoter just upstream of Renilla lucifer-
ase, Promega, Madison, WI) were mixed and transfected into
THP-1 cells or THP-1 cells persistently infected with MeV
using Superfect reagent (Qiagen) according to the manufac-
ture's instruction manual. After cultivation for 24 h, the cells
were treated with active vitamin D3 for 12 h. The transfected
cells were treated or not treated with 100 ng/ml LPS for
12 h. The cells were lysed, and the firefly luciferase and
Renilla luciferase activities were measured. The experiments
were performed in triplicate. Reporter activity was calculated
as the ratio of firefly luciferase activity to Renilla luciferase
activity.
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